Cooper Companies (The) (COO) : Fridays money flow analysis of Cooper Companies (The) (COO) indicates the selling of stock on the strength of price. The investors sold the stock on every rise as seen in the downtick transactions of $1.99 million. In comparison, the inflow of money on upticks was a meager $0.66 million. The dollar value of composite uptick trades minus the downtick trades was negative $1.33 million. The uptick to downtick ratio of 0.33 in the money flow shows weakness. The downtick transaction value was high at $0 million, which denotes distribution on strength.. Hence, the net money flow in the stock was negative ($0 million). Cooper Companies (The) (COO) gained $0.24 at $185.61, a change of 0.13% over the previous days close.
The company Insiders own 2.2% of Cooper Companies (The) shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -49.46% . Institutional Investors own 99.3% of Cooper Companies (The) shares. During last six month period, the net percent change held by insiders has seen a change of -49.46%.
In a related news, The Securities and Exchange Commission has divulged that Kalkstein Michael, director of Cooper Companies Inc, had unloaded 1,000 shares at an average price of $178.55 in a transaction dated on July 8, 2016. The total value of the transaction was worth $178,550.
Cooper Companies (The) (NYSE:COO): The stock opened at $185.35 and touched an intraday high of $189.35 on Friday. During the day, the stock corrected to an intraday low of $182.27, however, the bulls stepped in and pushed the price higher to close in the green at $185.92 with a gain of 0.30% for the day. The total traded volume for the day was 646,720. The stock had closed at $185.37 in the previous trading session.
Cooper Companies (The) (COO) : Traders are bullish on Cooper Companies (The) (COO) as it has outperformed the S&P 500 by a wide margin of 1.8% in the past 4 weeks. The bullishness in the stock continues even in the near-term as the stock has returned an impressive 0.58%, relative to the S&P 500. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 1.09% in the last 1 week, and is up 1.67% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.
The Cooper Companies, Inc. (Cooper), is a global medical device company. The Company operates through two business units, CooperVision, Inc. (CVI) and CooperSurgical, Inc. (CSI). CooperVision is a global manufacturer providing products for contact lens wearers. CooperSurgical focuses on supplying womens health clinicians with products and treatment options to improve the delivery of healthcare to women. CooperSurgical products fall into three main segments based on the point of healthcare delivery: Hospital, Office and Fertility Clinic. CooperVision develops, manufactures and markets a range of monthly, two-week and single-use contact lenses, featuring advanced materials and optics. CooperVision is involved in correcting vision problems such as astigmatism, presbyopia and ocular dryness, and provides innovative contact lens solutions. The CooperVision Companys brands include Biofinity, Avaira and MyDay and CooperSurgical Companys brands include Advincula Arch, SeeClear and Mobius.